CCLSNZ 2021: the conference that almost wasn’t

February 2020 saw the first cases of Covid-19 appear in New Zealand. Over the following weeks borders were gradually closed and, as we know, New Zealand...

Street simulations to combat falls

By 2050, the number of people over 65 will have tripled worldwide and around one in three living at home will have at least one fall per year, according...

Contact lens-related keratitis in New Zealand

In the early Sixties, driven by the efforts of pioneering dentist-turned-contact lens manufacturer Eugene Hirst (original co-founder of Mortimer Hirst...

Light at the end of the lockdown tunnel

Roughly one year ago, the nation and the world were catapulted into our brand-new world of Covid-19 lockdown and home confinement. Fears began to surface...

Risk factors for conjunctival melanoma recurrence

Although conjunctival melanoma is uncommon, when diagnosed late it can lead to metastatic disease and even death. It is classified according to the American...

Chalkeyes presents: Plus ça change!

The Second World War had been over for 15 years by the time I was born, but it loomed large in my young life.

BOOK REVIEW: Clinical Procedures in Primary Eye Care (fifth edition) by David B Elliott

It has been almost a couple of decades since I first became acquainted with my very own Clinical Procedures in Primary Eye Care (second edition) textbook....

SPONSORED: ZEISS EQ Workplace - Streamline your refractive cataract workflow

The EQ Workplace from ZEISS is the latest addition to the ZEISS Cataract Suite that helps to streamline the refractive cataract workflow. From biometry,...

Matters of size: when is the cornea too large?

The cornea is the most significant refractive structure of the eye, contributing two-thirds of the eye’s refractive power, the remainder coming from the...

PRP and DR and anti-VEGF injections, DMO and agitation research review

Effect of panretinal photocoagulation on corneal sensation and tear function in patients with DRH Review: This study evaluated the effects of panretinal...

Examining the LEAD trial

The LEAD study or Laser Intervention in early stages of age-related macular degeneration (AMD) trial was a world-first study into the safety and efficacy...

Getting to grips with RPD and AMD

Late last year a world-leading study was launched concentrating specifically on reticular pseudodrusen (RPD) and why they appear to be a high-risk phenotype...

289 articles found

Bottom Banner Advert